Radiesse (CaHA) — The Comprehensive Deep Dive

What Radiesse actually is

CaHA is chemically identical to the mineral component of bone and teeth. It is fully biocompatible. The microspheres are perfectly spherical and uniform — designed to act as a structural scaffold for new collagen formation while remaining locally inert.

The product has been FDA-approved since 2006 and has more than 15 years of clinical data behind it. It is one of the few biostimulators with both volumising and biostimulating action in the same syringe.

How Radiesse works — the dual mechanism

Two effects, two timelines:

1. Immediate volume (day 0): the CMC gel carrier provides bulk on injection. The patient sees a real lift the moment they sit up. This is unlike Sculptra, which shows essentially no effect on day 1.
2. Biostimulator effect (months 3–12): the CMC gel is progressively resorbed (typically within 3–6 months). As the gel disappears, the CaHA microspheres remain and serve as a scaffold for fibroblast collagen synthesis. New Type I collagen is laid down around and between the microspheres. By month 12, the gel is gone and the new collagen has taken its place.

This is why Radiesse longevity often exceeds what you’d expect from gel resorption alone — the volume retention at 12–18 months is increasingly the patient’s own collagen, not the original product.

Standard (volumising) use

Full-strength Radiesse is the go-to product for areas needing structural support with immediate visible improvement. Key indications:

• Jawline definition — the gel viscosity and biostimulator effect both serve a defined jaw line well. Placed deep, supra-periosteal along the inferior border of the mandible.
• Chin projection — for retrognathic chins or projection enhancement in patients not wanting surgery. Often combined with deep mental crease support.
• Pre-jowl sulcus — the depression just anterior to the jowl, in front of the masseter. Filling this softens the apparent jowl significantly.
• Deep nasolabial folds — for moderate-to-deep folds in patients with adequate skin thickness. Not for very thin skin (palpability risk).
• Marionette lines — the vertical drop from oral commissure to chin.
• Hand rejuvenation — Radiesse has FDA approval for dorsal hand volumisation. The hand is one of its clearest indications: restoring the loss of subcutaneous tissue that reveals veins and tendons.

Areas where standard Radiesse is contraindicated or risky:

• Lips: texture and palpability are wrong. No.
• Tear trough: palpability risk in thin skin. Use HA or Alb-PRF.
• Glabella: high vascular risk, no.
• Very superficial placement anywhere: Radiesse is a deep product. Superficial placement = palpable lumps.

Hyperdilute Radiesse for skin tightening

One of the most interesting modern uses of Radiesse is in hyperdilute form — diluted with saline and/or lidocaine and placed in a subdermal plane for skin quality improvement rather than volume.

Dilution ratios:

• 1:1 dilution (1 ml Radiesse + 1 ml diluent) — moderate biostim effect, mild volumising. Often used for the lower face and jawline area.
• 1:2 dilution — lighter biostim, minimal volume effect. Used for neck, décolleté, upper arms.
• 1:4 or higher — almost pure biostimulator. Used for very large areas (full back, full upper arms) where skin quality is the only goal.

Why this works: the CaHA microspheres still trigger collagen induction; the lower concentration spreads the effect over a wider area without producing visible “lumps” of immediate volume. Result: skin tightening, improved firmness, reduced crepiness — typically over 3–6 months as collagen builds.

Best indications for hyperdilute Radiesse:

• Neck laxity (one of the cleanest indications)
• Décolleté (chest) skin quality and crepiness
• Upper arm laxity (“bat wing” area)
• Knees (a notoriously hard area to treat)
• Buttock crepiness
• Full-face skin quality in older patients

Protocol: typically 2–3 sessions, 6–8 weeks apart. Maintenance annually.

Injection technique — needle vs cannula

Two main techniques:

• Needle, deep linear-retrograde: for focal placement (jaw line, chin projection). 27G needle, deep to bone or in subdermal plane, slow injection withdrawing the needle.
• Cannula, fan distribution: for broader areas and hyperdilute applications. 22–25G cannula, entry point through a small skin nick, distributed in fan patterns. Lower vascular risk than needle.

Modern practice favours cannula for any area near major vessels (especially the perioral region, where the facial artery is mobile). The infraorbital and supraorbital areas should not be injected with Radiesse at all due to vascular risk.

Volume per session is typically 1.5–3 ml per side for facial work, more for hands or hyperdilute body work.

Side effects and complications

Common, expected:

• Swelling for 1–3 days
• Bruising at injection sites
• Tenderness for 1–5 days
• Temporary palpability of injected areas (resolves as the gel integrates)

Uncommon:

• Nodules — less common than with Sculptra, but possible especially in mobile or thin-skin areas. Usually palpable but not visible.
• Asymmetry — correctable with subsequent sessions.
• Visible product — if placed too superficially. Avoidable with technique.

Rare but serious:

• Vascular events — intra-arterial injection causes tissue ischaemia. Of particular concern with Radiesse because CaHA cannot be dissolved — unlike HA filler, there is no hyaluronidase rescue. Vascular safety with Radiesse depends entirely on placement technique. Hyaluronidase has no effect.
• Visual complications — reported but extremely rare. Glabella, nasal, and infraorbital injection with Radiesse is contraindicated for this reason.
• Late-onset inflammation — rare delayed inflammatory response, sometimes triggered by infection elsewhere in the body. Responds to anti-inflammatory management.

Longevity and what to expect

Typical timeline:

• Day 0: immediate volume from the gel.
• Weeks 1–2: swelling resolves, true result visible.
• Months 3–6: gel gradually resorbs but collagen builds — the volume often remains stable or even improves slightly.
• Months 6–12: peak collagen contribution.
• Months 12–18: gradual loss of volume as collagen begins to remodel.
• Beyond 18 months: most patients have lost the majority of effect.

Hyperdilute Radiesse follows a similar timeline but the visible change is more gradual throughout — there’s less immediate effect to start with and more collagen-driven improvement over months.

Post-treatment care

• No vigorous massage — unlike Sculptra, Radiesse does not need (or want) aggressive massage. Light pressure for shaping is fine.
• Cold compresses for swelling.
• Avoid heavy exercise for 24 hours.
• Sleep on back for 2–3 nights.
• No facial RF or laser over the treated area for 2 weeks.
• Dental work: if you have dental work or invasive procedures scheduled, do them before Radiesse, not after — bacteremia can occasionally trigger late inflammation. Antibiotic cover is recommended for dental procedures within 2 weeks of injection.

Further reading

FAQ